We develop, manufacture and market a broad range of products across the US, Canada, the Middle East and North Africa, and Europe. We are a global business with 32 manufacturing plants and 7 R&D centres.
We manufacture injectable medicines in Europe, supplying products to the US, the MENA, and Europe. We have high-quality manufacturing plants in Germany, Italy and Portugal.
The region’s principal player, we create branded generic medicines and are a leading licensing partner. In MENA, we are one of the largest pharmaceutical companies and a ‘partner of choice’.
We are one of the top 3 manufacturers of generic injectable medicines in the US by volume (Source: IQVIA MAT through July 2022, generic injectable volumes by eaches, excluding branded generics and Becton Dickinson). We have a strong presence in the non-injectables market. We are a top-10 manufacturer of non-injectable generic medicines, including oral medications, as well as nasal sprays and inhalers. (Source: IQVIA FY 2021 non-injectable generic products only).
We market a rapidly growing and diversified portfolio of Health Canada-approved pharmaceuticals, including injectable and ophthalmic prescription medicines.
Our website uses cookies to improve your experience. Some of the cookies we use are essential for parts of our website to operate. By using our website without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.